Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
27Mar2020: Enrollment of new patients into this study has been paused due to the COVID‐19 situation. The duration of this pause is dependent on the leveling and control of the COVID‐19 pandemic.
Epistemonikos ID: b308923075e0895ba89b8605f36858e0d5be65c6
First added on: May 21, 2024